299. Cystic fibrosis
1,592 clinical trials,   1,539 drugs   (DrugBank: 255 drugs),   81 drug target genes,   162 drug target pathways

Searched query = "Cystic fibrosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02144246
(ClinicalTrials.gov)
May 201419/5/2014Contraceptive Hormones and Women With Cystic FibrosisContraceptive Hormones and Women With Cystic Fibrosis: Satisfaction and Effects on DiseaseCystic Fibrosis Exacerbations While on and Off Hormonal ContraceptionOther: Non-hormonal period;Drug: Ortho-cyclen, Ethinyl estradiol/norgestimate, 0.035 mg/0.250 mgUniversity of PennsylvaniaSociety of Family PlanningTerminated18 Years40 YearsFemale5Phase 1United States
2NCT02036879
(ClinicalTrials.gov)
February 201426/12/2013Gender Disparity and Hormones in Cystic FibrosisGender Disparity and Hormones in Cystic FibrosisCystic Fibrosis (CF)Drug: Loestrin (norethindrone acetate and ethinyl estradiol)University of Texas Southwestern Medical CenterNULLCompleted18 YearsN/AAll55Early Phase 1United States